PRIMARY PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS: AN OPEN LABELED RANDOMIZED CONTROLLED TRIAL OF LACTULOSE VERSUS NO LACTULOSE

被引：2
|
作者：
Agrawal, A. [1 ]
Sharma, P. [1 ]
Sharma, B. C. [1 ]
Sarin, S. K. [2 ]
机构：
[1] GB Pant Hosp, New Delhi, India
[2] Inst Liver & Biliary Sci, New Delhi, India
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)60614-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
601
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [31] Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy
    Chow, Kenneth W.
    Ibrahim, Brittney M.
    Yum, Jung J.
    Dang, An
    Dang, Long
    Chen, Kuan-Ting
    Jackson, Nicholas J.
    Saab, Sammy
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2389 - 2397
  • [32] Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial
    Attapon Rattanasupar
    Arunchai Chang
    Keerati Akarapatima
    Thanongsak Chaojin
    Teerha Piratvisuth
    Indian Journal of Gastroenterology, 2021, 40 : 621 - 629
  • [33] Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial
    Rattanasupar, Attapon
    Chang, Arunchai
    Akarapatima, Keerati
    Chaojin, Thanongsak
    Piratvisuth, Teerha
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2021, 40 (06) : 621 - 629
  • [34] EFFECT OF USING LACTULOSE AND RIFAXIMIN IN COMPARISON WITH LACTULOSE ONLY THERAPY IN TREATEMENT OF HEPATIC ENCEPHALOPATHY: A RANDOMIZED CONTROLLED TRIAL.
    Akbar, Muneeba
    Jabeen, Moqadsa
    Nayyer, Faiqua
    Maryam
    Sardar, Usama
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (05): : 3259 - 3262
  • [35] An open label randomised controlled trial of probiotics for primary prophylaxis of hepatic encephalopathy in patients with cirrhosis
    Lunia, Manish Kumar
    Sachdeva, Sanjeev
    Srivastava, Siddharth
    Sharma, Brijesh Chander
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 241 - 241
  • [36] AN OPEN LABEL RANDOMISED CONTROLLED TRIAL OF PROBIOTICS FOR PRIMARY PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
    Lunia, M. K.
    Sharma, B. C.
    Sachdeva, S.
    Srivastava, S.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S35 - S35
  • [37] Factors associated with nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy
    Qureshi, Muhammad Omar
    Shafqat, Farzana
    Salih, Mohammad
    Khokhar, Nasir
    RAWAL MEDICAL JOURNAL, 2014, 39 (02): : 115 - 118
  • [38] Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis
    Praveen, S.
    Chander, S. B.
    Kumar, S. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A142 - A142
  • [39] Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis
    Sharma, Praveen
    Sharma, Barjesh Chander
    Sarin, Shiv Kumar
    LIVER INTERNATIONAL, 2009, 29 (09) : 1365 - 1371
  • [40] A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
    Sharma, Barjesh Chander
    Sharma, Praveen
    Lunia, Manish Kumar
    Srivastava, Siddharth
    Goyal, Rohit
    Sarin, S. K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09): : 1458 - 1463
12345